Business Name: |
Cavallaro Ostrov Morere Boyar & Jameson |
Address: |
700 Mcclellan St, Schenectady, New York 12304 |
Phone Number: |
No number given |
Annual Revenue (USD): |
$100.000 to $499.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
621111 |
Share This Business: |
|
Related Businesses: |
Reilly Michael J MD - Schenectady, NY 12304 Us Oncology Inc - Schenectady, NY 12304 Mittal Peeyush MD - Schenectady, NY 12304 Barrowman Roger A MD - Schenectady, NY 12304 Fraterrigo Lynn E MD - Schenectady, NY 12304 Crafts Robert MD - Schenectady, NY 12304 Mc Grinder Gerard J MD - Schenectady, NY 12304 Lee Ernest MD - Schenectady, NY 12304 Schingo Jr Victor A MD - Schenectady, NY 12304 Wade Nancy A MD - Schenectady, NY 12304 Boler Lynn MD - Schenectady, NY 12304 Madden Jeena MD - Schenectady, NY 12304 Kaplan Irina Inna MD - Schenectady, NY 12304 Etienne Mineke E MD - Schenectady, NY 12304 Anumula Praveen MD - Schenectady, NY 12304 Chapados Gilles MD - Schenectady, NY 12304 Lee Arthur MD - Schenectady, NY 12304 Michael G Katlan - Schenectady, NY 12304 Fraterrigo Philip A MD - Schenectady, NY 12304 Rice Donald MD - Schenectady, NY 12304 |
The company Cavallaro Ostrov Morere Boyar & Jameson provides B2C services in the form of Doctors from its single location in New York.
1 to 4 employees work for Cavallaro Ostrov Morere Boyar & Jameson, and the business now earns $100.000 to $499.999 per annum.
Cavallaro Ostrov Morere Boyar & Jameson was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 .
To contact Cavallaro Ostrov Morere Boyar & Jameson, please call with the phone number No number given or visit its single location at 700 Mcclellan St in Schenectady, New York 12304.
The location of the single location can also be found using the coordinates .
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.